Michael D. Radmacher

11.0k citations

51 papers · 5.0k indexed · 2 hit papers · h-index 28

Molecular Biology top 2%
Hematology top 0.5%
Cancer Research top 1%
Genetics top 1%
Public Health, Environmental and Occupational Health top 5%

Co-authors: Richard Simon Lisa M. McShane Kevin K. Dobbin Guido Marcucci Clara D. Bloomfield Krzysztof Mrózek Susan P. Whitman Richard A. Larson
Topics: Acute Myeloid Leukemia Research (28 papers)Chronic Myeloid Leukemia Treatments (10 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers)
Cited by: Hematology Cancer Research Genetics
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Clinical Oncology
Partner nations: United States Germany Malaysia

In The Last Decade

Michael D. Radmacher

51 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification

2003 747 citations Richard Simon, Michael D. Radmacher et al. JNCI Journal of the National Cancer Institute profile →
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

2010 548 citations Guido Marcucci, Kati Maharry et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Michael D. Radmacher

Since Specialization

Citations

This map shows the geographic impact of Michael D. Radmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Radmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Radmacher more than expected).

Fields of papers citing papers by Michael D. Radmacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Radmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Radmacher. The network helps show where Michael D. Radmacher may publish in the future.

Co-authorship network of co-authors of Michael D. Radmacher

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Radmacher. A scholar is included among the top collaborators of Michael D. Radmacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Radmacher. Michael D. Radmacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study 2011 ·Haematologica ·Heiko Becker,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Klaus H. Metzeler,Susan P. Whitman,Sebastian Schwind,Jessica Kohlschmidt,Yaran Wu,Bayard L. Powell,Thomas H. Carter,Jonathan E. Kolitz,Meir Wetzler,A J Carroll,Maria R. Baer,Joseph O. Moore,M. A. Caligiuri,Richard A. Larson,Guido Marcucci,C. D. Bloomfield	18
2	The prognostic and functional role of microRNAs in acute myeloid leukemia 2010 ·Blood ·Guido Marcucci,Krzysztof Mrózek,Michael D. Radmacher,Ramiro Garzon,Clara D. Bloomfield	209
3	Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study 2009 ·Journal of Clinical Oncology ·Heiko Becker,Guido Marcucci,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Dean Margeson,Susan P. Whitman,Yue-Zhong Wu,Sebastian Schwind,Peter Paschka,Bayard L. Powell,Thomas H. Carter,Jonathan E. Kolitz,Meir Wetzler,Andrew J. Carroll,Maria R. Baer,Michael A. Caligiuri,Richard A. Larson,Clara D. Bloomfield	241
4	MicroRNA expression in acute myeloid leukemia 2009 ·Current Hematologic Malignancy Reports ·Guido Marcucci,Michael D. Radmacher,Krzysztof Mrózek,Clara D. Bloomfield	33
5	Molecular signatures in acute myeloid leukemia 2009 ·Current Opinion in Hematology ·Krzysztof Mrózek,Michael D. Radmacher,Clara D. Bloomfield,Guido Marcucci	30
6	Comparison of Clinical and Biologic Significance of WT1 Mutations in Populations of Older (≥60 years[y]) and Younger (<60 y) Adult Patients (Pts) with Cytogenetically Normal (CN) De Novo Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study. 2009 ·Blood ·Heiko Becker,Guido Marcucci,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Susan P. Whitman,Peter Paschka,Dean Margeson,Yue-Zhong Wu,Sebastian Schwind,Christian Langer,Maria R. Baer,Andrew J. Carroll,Michael A. Caligiuri,Jonathan E. Kolitz,Richard A. Larson,Clara D. Bloomfield	19
7	Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study 2008 ·Journal of Clinical Oncology ·Guido Marcucci,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Tamara Vukosavljevic,Peter Paschka,Susan P. Whitman,Christian Langer,Claudia D. Baldus,Chang‐Gong Liu,Amy S. Ruppert,Bayard L. Powell,Andrew J. Carroll,Michael A. Caligiuri,Jonathan E. Kolitz,Richard A. Larson,Clara D. Bloomfield	224
8	Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α 2008 ·Clinical Cancer Research ·Jason M. Zimmerer,Gregory B. Lesinski,Amy S. Ruppert,Michael D. Radmacher,(unknown),Kari Kendra,Michael J. Walker,William E. Carson	27
9	MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia 2008 ·New England Journal of Medicine ·Guido Marcucci,Michael D. Radmacher,Kati Maharry,Krzysztof Mrózek,Amy S. Ruppert,Peter Paschka,Tamara Vukosavljevic,Susan P. Whitman,Claudia D. Baldus,Christian Langer,Chang Gong Liu,Andrew J. Carroll,Bayard L. Powell,Ramiro Garzon,Carlo M. Croce,Jonathan E. Kolitz,Michael A. Caligiuri,Richard A. Larson,Clara D. Bloomfield	314
10	STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha 2007 ·Cancer Immunology Immunotherapy ·Jason M. Zimmerer,Gregory B. Lesinski,Michael D. Radmacher,Amy S. Ruppert,William E. Carson	31
11	Oxygen limitation modulates pH regulation of catabolism and hydrogenases, multidrug transporters, and envelope composition in Escherichia coli K-12 2006 ·BMC Microbiology ·(unknown),Jessica Wilks,Piero Sanfilippo,Elizabeth Yohannes,(unknown),Brian D. Jones,Michael D. Radmacher,Sandra Splinter BonDurant,Joan L. Slonczewski	115
12	Gross, histologic, and gene expression characteristics of osteoarthritic articular cartilage of the metacarpal condyle of horses 2006 ·American Journal of Veterinary Research ·(unknown),Alicia L. Bertone,(unknown),Michael D. Radmacher	21
13	Appropriateness of some resampling‐based inference procedures for assessing performance of prognostic classifiers derived from microarray data 2006 ·Statistics in Medicine ·Lara Lusa,Lisa M. McShane,Michael D. Radmacher,Joanna H. Shih,George W. Wright,Richard Simon	12
14	Fine-needle aspiration biopsy of non-Hodgkin lymphoma for use in expression microarray analysis 2006 ·Cancer ·Quaid Morris,Jeff Palatini,(unknown),Michael D. Radmacher,Pierluigi Porcu	9
15	Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces 2005 ·American Journal of Physiology-Gastrointestinal and Liver Physiology ·Jonghan Kim,C. L. Bronson,William L. Hayton,Michael D. Radmacher,Derry C. Roopenian,John M. Robinson,Clark L. Anderson	118
16	pH Regulates Genes for Flagellar Motility, Catabolism, and Oxidative Stress in Escherichia coli K-12 2004 ·Journal of Bacteriology ·Lisa M. Maurer,Elizabeth Yohannes,Sandra Splinter BonDurant,Michael D. Radmacher,Joan L. Slonczewski	360
17	Design of studies using DNA microarrays 2002 ·Genetic Epidemiology ·Richard Simon,Michael D. Radmacher,Kevin K. Dobbin	123
18	Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data 2002 ·Bioinformatics ·Lisa M. McShane,Michael D. Radmacher,Boris Freidlin,Yu Ren,Ming‐Chung Li,Richard H. Simon	160
19	Estimation of Tamoxifen's Efficacy for Preventing the Formation and Growth of Breast Tumors 2000 ·JNCI Journal of the National Cancer Institute ·Michael D. Radmacher,Richard Simon	53
20	Chromosome abnormalities in malignant melanoma: 2000 ·Cancer Genetics and Cytogenetics ·Mark A. Nelson,Michael D. Radmacher,Richard H. Simon,Mikel Aickin,Jinming Yang,(unknown),Julia Emerson,Denise J. Roe,(unknown),Floyd H. Thompson,Jerry L. Bangert,Stanley P. L. Leong,Raymond Taetle,Sydney E. Salmon,Jeffrey M. Trent	25

About Michael D. Radmacher

Michael D. Radmacher is a scholar working on Hematology, Cancer Research and Genetics, having authored 51 papers that have together received 5.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). The work is most often cited by research in Hematology (2.0k citations), Cancer Research (1.4k citations) and Genetics (652 citations). Michael D. Radmacher has collaborated with scholars based in United States, Germany and Malaysia. Frequent co-authors include Richard Simon, Lisa M. McShane, Kevin K. Dobbin, Guido Marcucci, Clara D. Bloomfield, Krzysztof Mrózek, Susan P. Whitman, Richard A. Larson, Jonathan E. Kolitz and Bayard L. Powell. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact